Entering text into the input field will update the search result below

HIRU, UNTD, LIOX, APCVZ- HIRU IN THE PROCESS OF RESEARCHING NEW MEDS!

Nov. 05, 2010 1:59 PM ET
crwepicks profile picture
crwepicks's Blog
10 Followers
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

signup3m

Hiru Corporation

Hiru Corporation (PINK SHEETS:HIRU) (http://www.hirucorporation.com) subsidiary Jiangxi Shaungshi Pharmaceutical Co., Ltd (Shaungshi AHP) launched the Jiangxi Shaungshi Biological Medicines Institute.

Shuangshi AHP is currently researching several new veterinary drugs for development within the next two years. The company launched this new institute to strengthen and speed up the research and development processes. The Institute will allow the company a better focus and concentration of its talent in bio-tech development and research. Shaungshi AHP has elected Li Rui to be director of the institute.

The company intends to continue its work in the development, production and marketing of both well-established and new veterinary drugs, and nutritional additives (amino acids, vitamins, trace elements, etc.) for the Chinese market.

The company is pleased with this development and looks forward to future growth.

United Online, Inc. (Nasdaq:UNTD) a leading provider of consumer products and services over the Internet, announced that its Board of Directors has declared a quarterly cash dividend of $0.10 per share.
The dividend is payable on November 30, 2010 to shareholders of record on November 12, 2010. This marks the 23rd consecutive quarter that United Online will have paid a cash dividend to its shareholders. The payment of future dividends is discretionary and will be subject to determination by the Board of Directors each quarter following its review of the company’s financial performance and other factors.
United Online, Inc. (Nasdaq:UNTD) is a leading provider of consumer products and services over the Internet, where the company’s brands have attracted a large online audience that includes more than 60 million registered consumer accounts.


Lionbridge Technologies Inc. (Nasdaq:LIOX) lost more money in its third quarter than a year ago, pulled down by higher operating expenses. The company also gave a fourth-quarter revenue guidance below analysts' expectations. Its stock slumped $1.14, or 22.8 percent, to $3.86 in afternoon trading on Thursday November 4, 2010. The shares have traded between $1.85 and $6.21 over the past year.
Lionbridge Technologies, Inc. provides language, development, and testing services. Its Global Language and Content segment provides product localization services, such as creating foreign language versions of its clients? products and software applications, including the user interface, online help systems, and documentation; and content translation services, such as translating and maintaining clients? Web-based content, eLearning courseware and training materials, technical support, and sales and marketing information.


Fresenius Kabi Pharmaceuticals (Nasdaq:APCVZ) announced that it has filed its Form 10-Q with the Securities and Exchange Commission. APP Pharmaceuticals, Inc., which was acquired by Fresenius Kabi Pharmaceuticals Holding, Inc., is a member of the Fresenius Kabi Group. The Form 10-Q details the Company’s unaudited financial statements for the quarter ending September 30, 2010. Fresenius Kabi AG is the leader in infusion therapy and clinical nutrition in Europe and in its most important countries of Latin America and Asia Pacific. Fresenius Kabi’s core product range includes infusion solutions, blood volume substitutes, I.V. drugs and parenteral nutrition, as well as products for enteral nutrition.

*******************************************
Sign-Up For Free Stock Alerts At http://crwepicks.com/signup
*******************************************

business Card 3

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.The CRWEPicks.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer ( http://crwepicks.com/disclaimer ) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEPicks.com report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. ( read more at http://crwepicks.com/disclaimer ) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (OTCPK:CRWE) has received five thousand dollars and anticipates receiving another forty five thousand dollars in cash from a third party for (thirty) days of advertising for Hiru Corporation (OTCPK:HIRU).

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You